Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

aXichem AB: aXichem signs agreement with BART regarding distribution and sales of aXivite® in Poland

aXichem
Read the release

aXichem AB (publ), that develops and markets natural analogue industrial compounds, has signed a marketing, sales and distribution agreement with the Polish company Bart Spólka Sp.k. (BART) (https://bart.pl/) a producer and supplier of ingredients for dietary supplements, food and beverages in a number of counties in eastern Europe. Under the agreement BART has the exclusive right to distribute and sell aXichem's capsaicin analogue product, aXivite (https://www.axichem.com/products/nutraceuticals/), on the Polish market.

- Entering this the agreement with BART aXichem has added yet another well-established distributor in the food supplement and nutrition segment in Europe. BART not only has the sales and distribution knowledge, but also, within its organization, through two innovative subsidiaries, resources in production and product development. I discern that they can provide aXivite with the best conditions for success on the Polish market, says Lucas Altepost, Vice President of aXichem.

According to Euromonitor and Statista.com consumers in Poland in 2019 spent more than 1.27 billion Euro on supplements. It is expected that the market's value will reach over 1,32 billion Euro in 2020. In 2020 consumers stockpile dietary supplements with immunity positioning in the wake of Coronavirus. 

This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.